Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/21/2000US6150091 Direct molecular diagnosis of Friedreich ataxia
11/21/2000US6150090 Nuclear factors associated with transcriptional regulation
11/21/2000US6150089 Method and characterizing polymer molecules or the like
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000US6150081 Nucleated with peptizer
11/21/2000US6149936 DNA expression vectors for the use in the gene therapeutic treatment of vascular disorders
11/21/2000US6149920 Vaccine for immunization, prophylaxis or treatment of a vertebrate at risk of or suffering from brucellosis, wherein said vaccine comprises an attenuated or avirulent strain of an otherwise pathogenic bacteria of the genus brucella
11/21/2000US6149919 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
11/21/2000US6149916 Methods of accelerating wound healing or of stimulating connective tissue cell growth using connective tissue growth factor
11/21/2000US6149911 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
11/21/2000US6149906 Activation of t-lymphocytes and induction of antigen-specific immune responses; preventing, treating various diseases ( viral, bacterial, fungal), botulism toxin, poison ivy, poison sumac
11/21/2000US6149902 Manipulation of non-terminally differentiated cells using the notch pathway
11/21/2000US6149867 Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
11/21/2000CA2166691C Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development
11/21/2000CA2159081C Dinucleotide restriction endonuclease preparations and methods of use
11/21/2000CA2089362C Methods of synthesizing oligonucleotides with random codons
11/21/2000CA2051090C Cephalosporin c acylase
11/21/2000CA1341143C Purified thermostable enzyme
11/21/2000CA1341142C Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
11/16/2000WO2000068690A1 Method for detecting proteins under mutual interaction
11/16/2000WO2000068687A2 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000WO2000068434A2 Multiple tag analysis
11/16/2000WO2000068432A2 Diagnosis of primary congenital glaucoma
11/16/2000WO2000068429A2 Diagnosis of glaucoma
11/16/2000WO2000068428A1 Methods for producing modified nucleic acid molecules
11/16/2000WO2000068426A1 Ups
11/16/2000WO2000068421A2 Method for detecting microorganisms in a sample
11/16/2000WO2000068420A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000WO2000068416A2 Method for localising proteases which split substrates that are specifically connected by a membrane
11/16/2000WO2000068414A2 Whole cell assay for cathepsin k
11/16/2000WO2000068411A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
11/16/2000WO2000068406A2 Disease resistance factors
11/16/2000WO2000068405A2 Plant defensins
11/16/2000WO2000068404A1 Maize rad50 orthologue and uses thereof
11/16/2000WO2000068403A2 Tapetum-specific promoters
11/16/2000WO2000068402A1 Manipulation of fructan catabolism in plants
11/16/2000WO2000068401A1 Recombinant penicillium funiculosum for homologous and heterologous protein production
11/16/2000WO2000068400A1 Method for producing a recombinant protein
11/16/2000WO2000068399A2 Vector-mediated delivery of integrating transposon sequences
11/16/2000WO2000068397A1 Biological tagatose production by recombinant escherichia coli
11/16/2000WO2000068396A2 Bacillus circulans xylanase mutants
11/16/2000WO2000068395A2 Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof
11/16/2000WO2000068394A1 Epoxide hydrolases of aspergillus origin
11/16/2000WO2000068393A1 Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof
11/16/2000WO2000068392A1 Plant-derived antigens against respiratory syncytial virus
11/16/2000WO2000068391A1 Expression of a mannan binding domain to alter plant morphology
11/16/2000WO2000068390A2 Plant recombination proteins
11/16/2000WO2000068389A2 Auxin transport proteins
11/16/2000WO2000068388A1 Seed specific promoters
11/16/2000WO2000068387A2 Nucleic acids and proteins with interferon-beta activity
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS
11/16/2000WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000WO2000068382A1 PrP-LIKE GENE
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068378A1 Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
11/16/2000WO2000068377A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068375A2 Modified pm and pu promoters of tol plasmids
11/16/2000WO2000068374A1 Regulation of viral gene expression
11/16/2000WO2000068373A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000WO2000068372A1 Combinatorial metabolic libraries
11/16/2000WO2000068371A1 Method of cell cultivation
11/16/2000WO2000068370A2 ib00180US MAIS
11/16/2000WO2000068368A1 Methods for constructing dna library and support carrying dna library immobilized thereon
11/16/2000WO2000068367A1 Assay reagent
11/16/2000WO2000068362A2 Undifferentiated erythroid cells and their use in ligand binding assays
11/16/2000WO2000068361A1 Versican and epithelial-mesenchymal interaction
11/16/2000WO2000068360A1 A histidine kinase, 636 hk, of staphylococcus aureus
11/16/2000WO2000068358A1 Method and device for extracting dna, rna and proteins from biological samples
11/16/2000WO2000068268A1 Human gabab receptor 1 promoters
11/16/2000WO2000068266A1 Amyloid precursor protein protease and related nucleic acid compounds
11/16/2000WO2000068265A1 Antimicrobial theta defensins and methods of using same
11/16/2000WO2000068261A2 Attenuated microorganisms for the treatment of infection
11/16/2000WO2000068258A2 Compounds exhibiting an antibiotic activity
11/16/2000WO2000068253A1 Dna promoter sequence for gene expression
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068243A1 Methods using mechanisms of action of aroa
11/16/2000WO2000067803A1 Compositions and methods for improving learning and memory
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000067786A1 PRODUCTION OF NOVEL NEWCASTLE DISEASE VIRUS STRAINS FROM cDNAS AND IMPROVED LIVE ATTENUATED NEWCASTLE DISEASE VACCINES
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067698A2 Method for controlling the fidelity and execution of reverse transcriptase by incorporating and polymerising nucleotide analogues acceptable as substrates without blocking its elongation
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000067576A1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
11/16/2000WO2000067569A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000067568A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000067558A1 Regulation of gene expression in tobacco for manipulation of plant growth and secondary metabolism
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000047223A3 Viral vaccine
11/16/2000WO2000046376A3 Particles for gene therapy
11/16/2000WO2000044406A3 Dna vaccines against hantavirus infections
11/16/2000WO2000043530A3 Stabilisation of compositions comprising non-viral nucleic acid transfer compositions
11/16/2000WO2000043501A3 Ribozymes directed against the catalytic subunit of the human telomerase (htert)
11/16/2000WO2000042204A3 Trans-acting factors in yeast
1 ... 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 ... 4023